Identifying High-Dimensional Biomarkers for Personalized Medicine via Variable Importance Ranking

ISSN： 1054-3406

Source： Journal of Biopharmaceutical Statistics, Vol.18, Iss.5, 2008-09, pp. : 853-868

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenomic biomarkers for personalized medicine

By Chen James J Lin Wei-Jiun Chen Hung-Chia

Pharmacogenomics, Vol. 14, Iss. 8, 2013-06 ,pp. : 969-980

Future Medicine

Access to resources Recommend Favorite

A Mixture Dose–Response Model for Identifying High‐Dimensional Drug Interaction Effects on Myopathy Using Electronic Medical Record Databases

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 4, Iss. 8, 2015-08 ,pp. : 474-480

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic biomarkers in personalized medicine Genetische Biomarker in der stratifizierten Arzneimitteltherapie

By Dingermann Theo Zündorf Ilse

PHARMAKON, Vol. 1, Iss. 1, 2013-01 ,pp. : 12-20

Govi-Verlag

Access to resources Recommend Favorite

Is Small Really Beautiful? Nanosensors and Low Abundance Biomarkers for Personalized Medicine

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 11, Iss. 4, 2013-12 ,pp. : 295-308

Bentham Science Publishers

Access to resources Recommend Favorite

Personalized Medicine and Molecular Diagnostics for Obesity: Metabolic Systems Reconstruction and Gut Microbiome Biomarkers

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 9, Iss. 1, 2011-03 ,pp. : 67-75

Bentham Science Publishers

Access to resources Recommend Favorite